Answers are grounded in this paper and cite their sources.
Randomized trial investigates HIV-associated tuberculosis management in adults, highlighting persistent challenges.
) and is currently not widely available. Management of rifampicin-resistant TB now involves a 6month all-oral regimen for most patients, including PWH. While significant gains have recently been made toward decreasing mortality from HIV-associated TB, there are many ongoing challenges, some of which are being addressed in active clinical trials.
No takes yet. Share an insight, caveat, or question.
Meintjes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: